REGENXBIO Inc. (NASDAQ:RGNX) Q3 2024 Earnings Call Transcript
Operator: Welcome everyone to the Q3 2024 REGENXBIO Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
Regenxbio Inc. (RGNX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 4,892,902 | $51,326,542 | +8% | 3.02% |
| 2. | Integral Health Asset Management Bhagwan Jay Rao | 1,275,000 | $13,374,750 | +35% | 1.5% |
| 3. | Avidity Partners Management David Witzke And Michael Gregory | 1,132,564 | $11,880,596 | -13% | 0.6% |
| 4. | Balyasny Asset Management Dmitry Balyasny | 1,120,109 | $11,749,943 | +39% | 0.01% |
| 5. | Aquilo Capital Management Marc Schneidman | 930,708 | $9,763,127 | +3% | 7.4% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.00 | 49,000 | Large Shareholder, Other | 49,000 | 2015-09-22 | Filing | |
| $22.00 | 38,500 | Large Shareholder, Other | 38,500 | 2015-09-22 | Filing | |
| $22.00 | 87,500 | Large Shareholder, Other | 1,256,542 | 2015-09-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.11 | 10,000 | 11,286 | 2024-10-01 | Filing | ||
| $12.34 | 700 | 11,286 | 2024-09-03 | Filing | ||
| $11.50 | 9,300 | 11,986 | 2024-09-03 | Filing | ||
| $15.00 | 100 | 11,286 | 2024-08-01 | Filing | ||
| $14.59 | 400 | 11,386 | 2024-08-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,207,548 | $147,325,487 | 0% | |
| 2. | 4,440,838 | $79,713,043 | 0% | |
| 3. | 3,939,549 | $70,714,905 | 0% | |
| 4. | 2,631,220 | $47,230,399 | 0% | |
| 5. | 1,820,382 | $32,675,865 | 0% |
News See All
REGENXBIO Inc. (NASDAQ:RGNX) Q2 2024 Earnings Call Transcript
Operator: Welcome everyone to the Q2 2024 REGENXBIO's Earnings Conference Call. All lines have been placed on mute to prevent background noise.
Top 10 Small-Cap Stocks with Highest Upside Potential
Most giant companies start as small-cap, but by continuously developing and growing their earnings, their share price increases making them large or mega-cap companies, and along the way smart investors...
REGENXBIO Inc. (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to REGENXBIO's First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcript
REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.43 EPS, expectations were $-1.27. REGENXBIO Inc.
REGENXBIO Inc. (NASDAQ:RGNX) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to REGENXBIO's Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2023 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the REGENXBIO Inc. First Quarter 2023 Conference Call. Please be advised that today's conference is being recorded.
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2022 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to the Q4 and Full Year 2022 REGENXBIO Earnings Call. At this time, all participants are in a listen-only mode.
11 Cheap Healthcare Stocks To Invest In
Healthcare is one of the biggest sectors in the world. According to a research report, the healthcare consumer market size was $332.391 billion and is expected to reach $667.37 billion by 2028.
Billionaire Hedge Funds
